Global Cannabis Market by Type: Research Report Highlights Applications

Dec.19.2022
Global Cannabis Market by Type: Research Report Highlights Applications
Global cannabis market report by Research and Markets analyzes various applications of cannabis as textile, food, construction material, with a projected CAGR of 21.6%.

The "Global Cannabis Market Segmented by Type" report by Research and Markets analyzes the various applications of cannabis, such as textiles, food, and building materials. The report predicts a compound annual growth rate (CAGR) of 21.6% for the industry in the next five years, indicating that this percentage is likely to increase as many other countries have already legalized industrial cannabis or will do so in the near future.


The report also cited examples of successful cannabis applications throughout the year. A recent report found that cannabis powder could be used as an alternative feed for livestock. "According to the scientific opinion of the European Food Safety Authority's (EFSA) Panel on Additives and Products or Substances used in Animal Feed, hemp seeds and hemp cake can be used as feed materials for all animal species, with the inclusion rate varying due to the species," states a research and market press release. "Hemp oil, as a rich source of essential fatty acids, can also be used as a supplement in animal feed, while hemp seeds and hemp cake can serve as a source of fat and protein in animal diets.


According to the report, industrial hemp fibers made from cellulose, hemicellulose, lignin, and pectin also offer many benefits for textile use. "The benefits of hemp fibers include lighter product weight, lower energy consumption, and a smaller environmental footprint. Hemp fibers can be spun and woven, thus widely used in the textile industry," the research and marketing department stated. "In addition, hemp fibers are much stronger than cotton and do not mold. Hemp fibers have special properties such as strength, durability, and resistance to bacteria and fungi.


In addition to the increasing legalization worldwide, the report also points out that the rising use of cannabis seeds and oil in food, as well as the increase in chronic disease rates, are the two main driving factors behind the rising costs of cannabis. However, despite this, the long-term stigmatization of cannabis and restrictions on industrial cannabis in some countries continue to hinder its growth.


Other reports based on marijuana have been recently released, predicting similar growth in the marijuana industry. A report from the United Nations Conference on Trade and Development (UNCTAD) entitled "Commodity Overview: Industrial Hemp Special Issue" stated that the global marijuana market is expected to reach $18.1 billion by 2027. According to Marco Fugazza, the UNCTAD economist and report author, marijuana offers tremendous potential for both mature and developing countries. "The growing marijuana market provides important economic opportunities that all countries can take advantage of," commented Fugazza. "As a renewable product, the opportunities are sustainable, which is crucial as countries seek to promote economic development while protecting the environment.


A report from the Trade and Development Meeting recommends that "governments must clarify the legal status of cannabis as a non-narcotic drug." Once this is done, countries can begin to explore the many benefits provided by the cannabis plant. According to the report, the industrial hemp market has enormous potential in agriculture, textiles, recycling, automobiles, furniture, food and beverage, paper, building materials, and personal care, due to its versatility and functional characteristics. Additionally, cannabis can be an effective part of crop rotation, helping to maximize land use and increase farmers' income.


The use of cannabis for animals and livestock is still a contentious issue. While cannabis can help alleviate stress in cows as animal feed, a recent study found tetrahydrocannabinol (THC) in the systems of cows that consumed cannabis feed. In September, Idaho ceased the sale of CBD pet supplements as the safety of cannabis and cannabis-derived products in animal feed has not yet been determined by federal or state laws, according to the US Department of Agriculture.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
The UK High Court has ordered Chinese vape manufacturer Shenzhen SKE Technology to provide £569,039 ($776,000) in security for costs in its design infringement proceedings against Vapepen London and other defendants over its Crystal Bar vape product. The court did not accept the defendants’ main argument that recovering costs from a China-based company would face significant enforcement obstacles, but found that SKE had not sufficiently disclosed its own financial position. The order is procedural and does not determine the underlying infringement claims.
News
Aug.21
Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Holdings Limited will acquire 100% of PT Broad Far Indonesia through two wholly owned subsidiaries for approximately RMB 90 million. The Indonesian company manufactures and sells heat-not-burn tobacco sticks and provides OEM/ODM services. The sellers are part of a related-party group controlled by Huabao International Chair and controlling shareholder Zhu Linyao. PT Broad Far Indonesia generated $4.37 million in revenue and $177,000 in profit after tax in the first half of 2026, while net assets stood at about $326,000 at June-end. An independent valuer assessed the company’s equity at approximately RMB 93.06 million. Following completion, the HNB manufacturing operation will be consolidated into Huabao International.
News
Sep.29 by 2Firsts Perspectives
Australia-China Operation Dismantles Tobacco Smuggling Network: 112 Containers, 60 Arrests and A$92 Million in Illicit Tobacco
Australia-China Operation Dismantles Tobacco Smuggling Network: 112 Containers, 60 Arrests and A$92 Million in Illicit Tobacco
According to The Maritime Executive on August 19, 2026, the Australian Border Force (ABF) and China’s Anti-Smuggling Bureau of General Administration of China Customs worked together to dismantle an international illicit tobacco smuggling network targeting Australia. According to information released by ABF on August 20, sustained information sharing and cooperation led to investigations into 112 shipping containers, with 91 found to contain illicit tobacco. Authorities seized more than 60 million cigarettes and 60 kilograms of loose-leaf tobacco, representing more than A$92 million in unpaid duties. More than 60 people suspected of involvement in the network were arrested in China.
Aug.20
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives